Assessment of adverse events related to anti-interleukin-6 receptor monoclonal antibodies using the FDA adverse event reporting system: a real-world pharmacovigilance study
Article in Expert Opinion on Drug Safety (July 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases
Article in European Journal of Pharmaceutical Sciences (November 2023)
Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice
Article in Frontiers in Immunology (April 2023)